The evolving landscape of brain metastasis
Type de document :
Article dans une revue scientifique: Article de synthèse/Review paper
PMID :
URL permanente :
Titre :
The evolving landscape of brain metastasis
Auteur(s) :
Valiente, Manuel [Auteur]
Ahluwalia, Manmeet S. [Auteur]
Boire, Adrienne [Auteur]
Brastianos, Priscilla K. [Auteur]
Goldberg, Sarah B. [Auteur]
Lee, Eudocia Q. [Auteur]
Le Rhun, Emilie [Auteur]
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
Preusser, Matthias [Auteur]
Winkler, Frank [Auteur]
Soffietti, Riccardo [Auteur]
Ahluwalia, Manmeet S. [Auteur]
Boire, Adrienne [Auteur]
Brastianos, Priscilla K. [Auteur]
Goldberg, Sarah B. [Auteur]
Lee, Eudocia Q. [Auteur]
Le Rhun, Emilie [Auteur]

Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
Preusser, Matthias [Auteur]
Winkler, Frank [Auteur]
Soffietti, Riccardo [Auteur]
Titre de la revue :
Trends in cancer
Nom court de la revue :
Trends Cancer
Numéro :
4
Pagination :
176-196
Date de publication :
2018-03-01
ISSN :
2405-8025
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Metastasis, involving the spread of systemic cancer to the brain, results in neurologic disability and death. Current treatments are largely palliative in nature; improved therapeutic approaches represent an unmet clinical ...
Lire la suite >Metastasis, involving the spread of systemic cancer to the brain, results in neurologic disability and death. Current treatments are largely palliative in nature; improved therapeutic approaches represent an unmet clinical need. However, recent experimental and clinical advances challenge the bleak long-term outcome of this disease. Encompassing key recent findings in epidemiology, genetics, microenvironment, leptomeningeal disease, neurocognition, targeted therapy, immunotherapy, and prophylaxis, we review preclinical and clinical studies to provide a comprehensive picture of contemporary research and the management of secondary brain tumors.Lire moins >
Lire la suite >Metastasis, involving the spread of systemic cancer to the brain, results in neurologic disability and death. Current treatments are largely palliative in nature; improved therapeutic approaches represent an unmet clinical need. However, recent experimental and clinical advances challenge the bleak long-term outcome of this disease. Encompassing key recent findings in epidemiology, genetics, microenvironment, leptomeningeal disease, neurocognition, targeted therapy, immunotherapy, and prophylaxis, we review preclinical and clinical studies to provide a comprehensive picture of contemporary research and the management of secondary brain tumors.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
INSERM
Université de Lille
Université de Lille
Date de dépôt :
2022-06-15T13:57:34Z
2023-04-21T10:02:39Z
2023-04-21T10:02:39Z